A High-Content Screening (HCS) Assay for the Identification of Chemical Inducers of PML Oncogenic Domains (PODs)

Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA.
Journal of Biomolecular Screening (Impact Factor: 2.42). 02/2011; 16(2):251-8. DOI: 10.1177/1087057110394181
Source: PubMed


PML is a multi-functional protein with roles in tumor suppression and host defense against viruses. When active, PML localizes to subnuclear structures named PML oncogenic domains (PODs) or PML nuclear bodies (PML-NBs), whereas inactive PML is located diffusely throughout the nucleus of cells. The objective of the current study was to develop a high content screening (HCS) assay for the identification of chemical activators of PML. We describe methods for automated analysis of POD formation using high throughput microscopy (HTM) to localize PML immunofluorescence in conjunction with image analysis software for POD quantification. Using this HCS assay in 384 well format, we performed pilot screens of a small synthetic chemical library and mixture-based combinatorial libraries, demonstrating the robust performance of the assay. HCS counter-screening assays were also developed for hit characterization, based on immunofluorescence analyses of the subcellular location of phosphorylated H2AX or phosphorylated CHK1, which increase in a punctate nuclear pattern in response to DNA damage. Thus, the HCS assay devised here represents a high throughput screen that can be utilized to discover POD-inducing compounds that may restore the tumor suppressor activity of PML in cancers or possibly promote anti-viral states.

Download full-text


Available from: Marc A Giulianotti, Oct 05, 2015
50 Reads
  • Source
    • "Audebert et al. reported the development of an in vitro genotoxicity assay system using γ-H2AX measurement to evaluate the effects of food poisons such as benzo(a)pyrene, fluoranthene, and 3-methylcholanthrene [37]. In addition to the automated high throughput RABIT system discussed above [17,18], one high-content screening assay [38] and two enzyme-linked immunosorbent assays (ELISA) that can accurately quantify γ-H2AX level, one for screening genotoxic molecules [39] and one for clinical trials [25] have been developed. These tools will greatly increase the capacity to identify genotoxic compounds, not only to humans, but also in other organisms. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The past year has seen considerable developments in the use of the DNA double-strand breaks (DSBs) to evaluate genome alterations in cells undergoing a variety of genotoxic stresses in vitro and in vivo. When the γ-H2AX foci which mark the DSBs are stained, individual breaks are detectible, making the assay suitable for situations requiring great sensitivity. While the methods for the detection of γ-H2AX foci are still evolving, particularly for in vivo detection, the basic assay has proven to be useful in several diverse areas of research. We will highlight recent developments of the assay in four areas: radiation biodosimetry, the evaluation or validation of new cancer drugs in clinical studies, chronic inflammation, and environmental genotoxicity.
    Aging 02/2011; 3(2):168-74. · 6.43 Impact Factor
  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiologic agent associated with Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman disease (MCD). Similar to other herpesviruses, KSHV has two life cycles, latency and lytic replication. In latency, the KSHV genome persists as a circular episome in the nucleus of the host cell and only a few viral genes are expressed. In this review, we focus on oncogenic, antiapoptotic, and immunomodulating properties of KSHV-encoded homologues of cellular interferon regulatory factors (IRFs)—viral IRF1 (vIRF1) to vIRF4—and their possible role in the KSHV-mediated antiviral response, apoptosis, and oncogenicity.
    Journal of Virology 06/2013; 87(17). DOI:10.1128/JVI.03315-12 · 4.44 Impact Factor
Show more